Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/12/2018
SIETES contiene 92610 citas

 
 
 1 a 20 de 598 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
2. Cita con resumen
Harrington M, Sigal EV. Opinion: ‘Right-to-try’ law threatens patient safety and rational drug development. STAT Daily Recap 2018:6. [Ref.ID 102467]
4.
Hampp C, Pippins J. Pioglitazone and bladder cancer: FDA's assessment. Pharmacoepidemiol Drug Saf 2017;26:117-8. [Ref.ID 101950]
5.Tiene citas relacionadas Cita con resumen
Bhatt DL, Mehta C. Adaptive designs for clinical trials. N Engl J Med 2016;375:65-74. [Ref.ID 100614]
6. Cita con resumen
Solans-Domènech M, Permanyer-Miralda G. Evaluación del impacto de la investigación biomédica: ¿para quién?. Med Clin (Barc) 2016;146:491-3. [Ref.ID 100373]
7. Cita con resumen
8. Cita con resumen
Stafford N. German drug industry says pricing law is restricting access to some drugs. BMJ 2015;351:h6205. [Ref.ID 99692]
9. Cita con resumen
Maynard A, Bloor K. Regulation of the pharmaceutical industry: promoting health or protecting wealth?. J R Soc Med 2015;108:220-2. [Ref.ID 99099]
10.Tiene citas relacionadas Cita con resumen
Köhler M, Haag S, Biester K, Brockhaus AC, McGauran N, Grouven U, Kölsch H, Seay U, Hörn H, Moritz G, Staeck K, Wieseler B. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports. BMJ 2015;350:h796. [Ref.ID 98850]
11.Tiene citas relacionadas Cita con resumen
Doshi P, Jefferson T. The evidence base for new drugs. BMJ 2015;350:h952. [Ref.ID 98849]
13.Tiene citas relacionadas Cita con resumen
Mäkelä KT, Matilainen M, Pulkkinen P, Fenstad AM, Havelin L, Engesaeter L, Furnes O, Pederson AB, Overgaard S, Kärrholm J, Malchau H, Garellick G, Ranstam J, Eskelinen A. Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ 2014;348:14. [Ref.ID 97252]
14.Tiene citas relacionadas
Hamilton DF, Howie CR. Selecting the right hip replacement. BMJ 2014;348:g46. [Ref.ID 97250]
15. Cita con resumen
Iannone P, Haupt E, Flego G, Truglio P, Minardi M, Clarke S, Magrini N. Dronedarone for atrial fibrillation: the limited reliability of clinical practice guidelines. JAMA Intern Med 2014;174:625-9. [Ref.ID 97190]
16. Cita con resumen
Anónimo. Drug assessment: UK style. Drug Ther Bull 2013;51:141-4. [Ref.ID 96627]
17.Tiene citas relacionadas Cita con resumen
Smith MEB, Totten A, Hickam DH, Fu R, Wasson N, Rahman B, Motu'apuaka M, Saha S. Pressure ulcer treatment strategies: a sytematic comparative effectiveness review. Ann Intern Med 2013;159:39-50. [Ref.ID 95856]
18.Tiene citas relacionadas Cita con resumen
Chou R, Dana T, Bougatsos C, Blazina I, Starmer AJ, Reitel K, Buckley DI. Pressure ulcer risk assessment and prevention: a systematic comparative effectiveness review. Ann Intern Med 2013;159:28-38. [Ref.ID 95855]
20. Cita con resumen
Toussaint B. EU clinical trial regulation. Lancet 2013;381:1719-20. [Ref.ID 95444]
Seleccionar todas
 
 1 a 20 de 598 siguiente >>